Skip to content

To Evaluate the Earthsukh Anti-Ageing activity of Ghee Based Balm

A Clinical Study to Evaluate the Earthsukh Anti-Ageing activity of Ghee Based Balm on Healthy Human Subjects - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070830
Enrollment
36
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ghee Based Balm: Dose: Apply half a pump over the full face with a finger in an outward manner. Duration- once a day at night. Route of administration- Topical Control Intervention1: No

Sponsors

Earthsukh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Non-pregnant, non-lactating female aged between 40 to 60. 2) Subjects willing to give written informed consent 3) Women of childbearing potential must have a negative urine pregnancy test before study entry. 4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breastfeeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3. Have open sores or open lesions in the treatment area(s). 4. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 5. Have participated in any interventional clinical trial in the previous 30 days. 6. Have a known sensitivity to any of the constituents of the test product 7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 8. Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

MeasureTime frame
Change in Skin moisturization, Elasticity, Melanin content, Lightness, Firmness, TEWLTimepoint: Day0, Day15 and Day 28

Secondary

MeasureTime frame
To assess the safety and tolerabilityTimepoint: Day0, and Day28

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026